Comments
Abbott hepatitis C combo impressive in small study
05.04.2012. | (Reuters) - A combination of experimental oral hepatitis C treatments being developed by Abbott Laboratories led to cure rates higher than 90 percent in previously untreated patients, according to data from a small mid-stage study....
